Department of Medical Genetics, Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, UK.
The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
Am J Hum Genet. 2014 Apr 3;94(4):618-24. doi: 10.1016/j.ajhg.2014.03.006. Epub 2014 Mar 27.
To identify further Mendelian causes of intellectual disability (ID), we screened a cohort of 996 individuals with ID for variants in 565 known or candidate genes by using a targeted next-generation sequencing approach. Seven loss-of-function (LoF) mutations-four nonsense (c.1195A>T [p.Lys399(∗)], c.1333C>T [p.Arg445(∗)], c.1866C>G [p.Tyr622(∗)], and c.3001C>T [p.Arg1001(∗)]) and three frameshift (c.2177_2178del [p.Thr726Asnfs(∗)39], c.3771dup [p.Ser1258Glufs(∗)65], and c.3856del [p.Ser1286Leufs(∗)84])-were identified in SETD5, a gene predicted to encode a methyltransferase. All mutations were compatible with de novo dominant inheritance. The affected individuals had moderate to severe ID with additional variable features of brachycephaly; a prominent high forehead with synophrys or striking full and broad eyebrows; a long, thin, and tubular nose; long, narrow upslanting palpebral fissures; and large, fleshy low-set ears. Skeletal anomalies, including significant leg-length discrepancy, were a frequent finding in two individuals. Congenital heart defects, inguinal hernia, or hypospadias were also reported. Behavioral problems, including obsessive-compulsive disorder, hand flapping with ritualized behavior, and autism, were prominent features. SETD5 lies within the critical interval for 3p25 microdeletion syndrome. The individuals with SETD5 mutations showed phenotypic similarity to those previously reported with a deletion in 3p25, and thus loss of SETD5 might be sufficient to account for many of the clinical features observed in this condition. Our findings add to the growing evidence that mutations in genes encoding methyltransferases regulating histone modification are important causes of ID. This analysis provides sufficient evidence that rare de novo LoF mutations in SETD5 are a relatively frequent (0.7%) cause of ID.
为了进一步确定智力障碍(ID)的孟德尔病因,我们使用靶向下一代测序方法对 996 名 ID 患者进行了 565 个已知或候选基因的变异筛查。我们发现 SETD5 基因中有七个失活(LoF)突变——四个无义突变(c.1195A>T [p.Lys399(∗)],c.1333C>T [p.Arg445(∗)],c.1866C>G [p.Tyr622(∗)],和 c.3001C>T [p.Arg1001(∗)]) 和三个移码突变(c.2177_2178del [p.Thr726Asnfs(∗)39],c.3771dup [p.Ser1258Glufs(∗)65],和 c.3856del [p.Ser1286Leufs(∗)84]),该基因编码一种甲基转移酶,被认为可能与 SETD5 基因有关。所有突变均符合新发显性遗传。受影响的个体表现为中重度 ID,伴有其他可变特征,包括短头畸形;明显的高额头伴并眉或突出的丰满而宽阔的眉毛;长而细的管状鼻子;长而窄的上斜型睑裂;以及大而肉质的低位耳朵。骨骼异常,包括显著的腿长差异,在两个个体中经常发现。先天性心脏缺陷、腹股沟疝或尿道下裂也有报道。行为问题,包括强迫症、有仪式性的手拍打和自闭症,是突出的特征。SETD5 位于 3p25 微缺失综合征的关键区间内。SETD5 突变患者表现出与以前报道的 3p25 缺失患者相似的表型,因此 SETD5 的缺失可能足以解释该病症中观察到的许多临床特征。我们的发现增加了越来越多的证据,表明调节组蛋白修饰的甲基转移酶基因的突变是 ID 的重要原因。该分析提供了充分的证据,表明 SEED5 中罕见的新生 LoF 突变是 ID 的一个相对常见(0.7%)原因。